Phaco technology platform

Article

The CENTURION Vision System sets a new standard of performance in cataract surgery by combining multiple, intelligent technologies and key features to provide surgeons control and improved efficiency during the cataract phaco procedure.

The CENTURION Vision System

The Only Intelligent Phacoemulsification Technology Designed to Optimize Cataract Surgery

Technology Overview and Unique Features
The CENTURION Vision System sets a new standard of performance in cataract surgery by combining multiple, intelligent technologies and key features to provide surgeons control and improved efficiency during the cataract phaco procedure.

The CENTURION Vision System is the only intelligent phaco technology that optimizes every moment of the cataract procedure. The new system automatically and continuously adapts to changing conditions within the eye, providing more consistent IOP (Intraocular Pressure) and greater anterior chamber stability during each step of the surgery. The CENTURION® Vision System places optimized energy technology at the surgeon's fingertips through enhanced fluidic management and surgical precision.1

Intelligent Technologies
Active Fluidics Technology is an automated system that optimizes anterior chamber stability by allowing surgeons to proactively set and maintain target IOP within the eye during the cataract procedure.1 This provides enhanced IOP control during the procedure in comparison to gravity fluidics and fixed pressure irrigation; reduces surges due to occlusion breaks; maintains a consistent IOP; and eliminates the need to manually adjust fluid pressure.

Balanced Energy Technology enhances phaco efficiency through proven OZil Intelligent Phaco and the INTREPID Balanced Tip probe. This increases efficiency and control, while reducing energy levels and accommodating surgeon settings for aspiration and vacuum by keeping the fragmented lens material at the shearing plane for emulsification.2,3

Applied Integration allows the CENTURION Vision System to be used seamlessly with multiple cataract surgical technologies, such as the LuxORTM Q-VUE surgical microscope platforms and the LenSX Laser from Alcon, to create a comprehensive cataract surgery suite designed to minimize variability at every step of the procedure.

The CENTURION Vision System also offers surgeons an improved ergonomic design, wireless footswitch and intuitive touch-screen display.

For more information about the CENTURION Vision system, please visit

www.centurionvisionsystem.com

References


1. Data on File, Alcon Laboratories.
2. A.R. Vasaveda

et al.

, Ophthalmic Surg. Lasers Imaging, 2010;

41

(1):109–114.
3. R.J. Cionni, A.S. Crandall and D. Felsted,

J. Cataract Refract. Surg.

, 2011;

37

(10):1795–1790.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
Related Content
© 2025 MJH Life Sciences

All rights reserved.